The role played by efflux transport systems across the blood-brain barrier
(BBB) in the disposition of xenobiotics in the brain is described. Several
drugs and organic anions are transported across the BBB via P-glycoprotein
and other carrier-mediated efflux transport systems. Studies using in vitro
cultured brain capillary endothelial cells, kinetic analysis, and mdr1a ge
ne knock-out mice have shown that P-glycoprotein, located on the BBB, restr
icts the entry of vincristine and quinidine to the brain. Brain microdialys
is studies have demonstrated that the brain interstitial fluid (ISF) concen
trations of quinolone antibiotics are significantly lower than their corres
ponding unbound serum concentrations. A distributed model analysis supports
the finding that efflux transport systems on the BBB restrict distribution
of 3'-azido-3'-deoxythymidine (AZT), 2',3'-dideoxyinosine (DDI), and quino
lone antibiotics. A brain efflux index (BEI) method has been developed to p
rovide direct evidence of an efflux transport system for carrying substrate
s from the cerebrum to the circulating blood across the BBB. The BEI method
revealed the existence of carrier-mediated efflux organic anion transport
systems for compounds such as p-aminohippuric acid, AZT, DDI, taurocholic a
cid, BQ-123, and estron sulfate. Moreover, cerebral neurotransmitters such
as gamma-aminobutyric acid, L-glutamic acid, and L-aspartic acid are transp
orted from brain to the circulating blood in the intact form via a carrier-
mediated efflux transport system. The BBB not only restricts nonspecific pe
rmeation from the circulating blood to the brain, but also functions as an
active efflux transport system for xenobiotics. Accordingly, the BBB plays
a very important role by pumping xenobiotics and some endogenous compounds
out of the brain, acting as a central nervous system (CNS)-specific detoxif
ying system supporting and maintaining normal cerebral function. (C) 1999 E
lsevier Science B.V. All rights reserved.